MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,168,000 | -89.6% | 38,918 | -92.3% | 0.03% | -90.2% |
| Q2 2016 | $30,606,000 | +30.8% | 507,570 | -0.3% | 0.28% | +29.5% |
| Q1 2016 | $23,407,000 | -21.4% | 509,072 | -17.4% | 0.22% | -21.4% |
| Q4 2015 | $29,780,000 | -12.9% | 616,079 | -23.5% | 0.28% | -5.4% |
| Q3 2015 | $34,208,000 | -82.3% | 804,912 | -52.5% | 0.30% | +2.4% |
| Q2 2015 | $193,539,000 | -11.1% | 1,694,740 | +0.5% | 0.29% | -13.7% |
| Q1 2015 | $217,696,000 | +27.9% | 1,686,657 | -1.3% | 0.34% | +21.8% |
| Q4 2014 | $170,239,000 | -26.5% | 1,709,055 | -27.0% | 0.28% | -30.6% |
| Q3 2014 | $231,583,000 | +22.2% | 2,342,299 | -4.7% | 0.40% | +28.2% |
| Q2 2014 | $189,516,000 | +20.2% | 2,458,698 | +0.4% | 0.31% | +18.4% |
| Q1 2014 | $157,673,000 | +780.2% | 2,449,494 | +772.7% | 0.26% | +770.0% |
| Q4 2013 | $17,913,000 | -18.3% | 280,685 | -23.3% | 0.03% | -23.1% |
| Q3 2013 | $21,930,000 | +45.2% | 365,876 | +19.2% | 0.04% | +30.0% |
| Q2 2013 | $15,102,000 | – | 306,957 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |